Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza... ( Using a multi-targeted siRNA cock...)

HOME >> BIOLOGY >> TECHNOLOGY

Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza Infection

Date:6/29/2010

"Using a multi-targeted siRNA cocktail to target various conserved regions across multiple influenza virus strains, we aim to develop a resistance-proof therapeutic approach for fighting constantly mutating influenza viruses," Dr. Evans indicated.

Sirnaomics, Inc. is a privately held Delaware corporation headquartered in Gaithersburg, Maryland, USA. Established in 2007 by a group of leading scientists in the field of RNAi technology, the company is pursuing the mission of advancing RNAi technology with novel targeted therapeutics development. In 2008, the company established its subsidiary in Suzhou, China to expand its R&D capacity and potential market. Members of the senior management team bring over 60 years of combined experience in the biopharmaceutical, financial and business management industries. Supported with funding from founders, angel investors, government grants and China-Singapore VC, Sirnaomics has developed a strong portfolio of intellectual property with an enriched product pipeline. The therapeutic areas of interest include scarless wound healing, pandemic flu (H5N1/H1N1), oncology, ocular diseases, spinal cord injury and transplantation.

For more information, visit www.sirnaomics.com or contact info-office@sirnaomics.com.

CONTACT: George Ji, +1-301-740-173
'/>"/>

SOURCE Sirnaomics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related biology technology :

1. Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics
2. Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics
3. Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
4. Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
5. China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group
6. Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of Acromegaly
7. Interleukin Genetics, Inc. Receives Delisting Notification from NYSE Amex
8. Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association
9. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
10. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
11. Aeterna Zentaris Receives US$12 Million on Closing of Registered Direct Offering

Post Your Comments:

(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...

(Date:5/23/2013)... Can economic incentives such as gift cards, T-shirts, ... public to increase their donations of blood? , A ... School Assistant Professor Mario Macis says the answer ... of recent research that supports their argument, the three ... Science that the World Health Organization and national blood ...

(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...

(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...

Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3 Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2 The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2 The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3

[0] Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology [0] Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science [0] Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home [0] The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments

... Heritage Labs, a,division of Hooper Holmes (Amex: ... a new at-home consumer product that measures the ... The Appraise(R) Home,A1c Kit provides consumers with an ... and reliable test results equivalent to whole,blood tests ...

... YORK, Aug. 7 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ... 11, 2008,at 8:30 a.m. EDT to discuss the second ... Executive Officer of the Company, will,host the call. Keryx ... press release to be issued prior to the call., ...

... (OTC Bulletin Board: GNTA) today announced financial results,for the ... in the second quarter, including the following:, -- ... -- AGENDA Phase 3 trial of Genasense in ... tesetaxel, a leading, clinical-stage oral taxane,lifted by FDA, ...

Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights

(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...

(Date:5/23/2013)... Given the implications for the overall health, development, ... a primary role in ensuring that all students ... minutes per day of vigorous or moderate-intensity physical ... of Medicine. Recent estimates suggest that only ... guideline for promoting better health and development. ...

(Date:5/23/2013)... 2013) A new report from the Institute of ... engage in at least 60 minutes of vigorous or ... more than half of American youth meet current evidence-based ... moderate intensity physical activity daily, according to the report, ... in school for nearly half of their waking hours, ...

Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2 Schools should provide opportunities for 60 minutes of daily physical activity to all students 2 Schools should provide opportunities for 60 minutes of daily physical activity to all students 3 Schools should provide students with daily physical activity, IOM recommends 2

[0] UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis [0] Schools should provide opportunities for 60 minutes of daily physical activity to all students [0] Schools should provide students with daily physical activity, IOM recommends

... 5, 2007) As if being admitted to the ... higher risk of becoming infected with a superbug bacterium, ... difficile kill human intestinal cells by causing them to ... fuel. This results in severe diarrhea and, in rare ...

... dog-walking in bushland significantly reduces bird diversity and ... practice in sensitive bushland and conservation areas. ... impacts of dog-walking have remained subjective and unresolved ... the first clear evidence that birds perceive dogs ...

... know. The supermarket headlines tell us so., Inquiring Texas ... B a tiny, sometimes obscure pest that can damage ... to young cotton for about four weeks," said Dr. ... Lubbock. "They feed on new plant growth, primarily the ...

Cached Biology News:Curbing C. difficile's toxin production 2 A dog in the hand scares birds in the bush 2 Inquiring minds want to know about cotton fleahoppers 2 Inquiring minds want to know about cotton fleahoppers 3

Curbing C. difficile's toxin production A dog in the hand scares birds in the bush Inquiring minds want to know about cotton fleahoppers

... simple and convenient method for the rapid, thorough ... optimized for use with S. cerevisiae and C. ... species that is susceptible to yeast lytic enzyme ... of yeast cells that are ideal for both ...

... pump series combines Harvard Apparatuss best pump mechanism, ... wide range of configuration options. A lookup table ... syringes from all the major manufacturers. A bright, ... pertinent information from across the lab. All models ...

... syringe pump series combines Harvard Apparatuss best pump ... a wide range of configuration options. A lookup ... of syringes from all the major manufacturers. A ... the pertinent information from across the lab. All ...

... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. Feature: tissue-culture treated yes ... cm 2 D H 60 ...

Biology Products:

Yeast Protein Kit from Zymo Research Programmable PHD2000 pump, microliter syringe rack (702011) from Instech Solomon Infuse/withdraw PHD2000 pump, 4x140 syringe rack (702007) from Instech Solomon Corning Petri Dish, 60 X 15 mm, Tc -Treated, Sterile from Sigma-Aldrich